HSDB 531 en es it fr

HSDB 531 Brand names, HSDB 531 Analogs

HSDB 531 Brand Names Mixture

  • No information avaliable

HSDB 531 Chemical_Formula


HSDB 531 RX_link


HSDB 531 fda sheet

HSDB 531 msds (material safety sheet)


HSDB 531 Synthesis Reference

No information avaliable

HSDB 531 Molecular Weight

46.0684 g/mol

HSDB 531 Melting Point

-114.1 oC

HSDB 531 H2O Solubility

Miscible in water

HSDB 531 State


HSDB 531 LogP


HSDB 531 Dosage Forms


HSDB 531 Indication

For therapeutic neurolysis of nerves or ganglia for the relief of intractable chronic pain in such conditions as inoperable cancer and trigeminal neuralgia (tic douloureux), in patients for whom neurosurgical procedures are contraindicated.

HSDB 531 Pharmacology

Alcohol produces injury to cells by dehydration and precipitation of the cytoplasm or protoplasm. This accounts for its bacteriocidal and antifungal action. When alcohol is injected in close proximity to nerve tissues, it produces neuritis and nerve degeneration (neurolysis). Ninety to 98% of ethanol that enters the body is completely oxidized. Ethanol is also used as a cosolvent to dissolve many insoluble drugs and to serve as a mild sedative in some medicinal formulations.

HSDB 531 Absorption

Rapidly absorbed.

HSDB 531 side effects and Toxicity

Oral, rat LD50: 5628 mg/kg. Symptoms and effects of overdose include nausea, vomiting, CNS depression, acute respiratory failure or death and with chronic use, severe health problems, such as liver and brain damage.

HSDB 531 Patient Information

No information avaliable

HSDB 531 Organisms Affected

Humans and other mammals